New panel for immuno-oncology – available now!

Takis has recently developed new assays to test in mouse models and in human PBMCs the activity of immune checkpoint inhibitors.

The assays allowed the screeening and the identification of candidates for clinical development.

 panel for Immune Oncology

Moreover, the possibility to follow 13 parameters at same time, allows to monitor how peripheral cell population changes over time in cancer patients treated with Immune Checkpoint modulators.


For more info, Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo.!